Arginine Uptake
Arginine Uptake - Related Videos
07:02
Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
0 Views •
Cited by 10 •
2021
The present protocol describes the preparation and quantitative measurement of free and protein-bound arginine and methyl-arginines by 1H-NMR spectroscopy.
07:48
Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis
0 Views •
Cited by 3 •
2019
The αvβ3 integrin is a type of adhesion protein that is highly expressed on activated endothelial cells undergoing angiogenesis. Thus, evaluating the integrity of the integrin is of great interest in oncology. Here, we introduce a method to prepare 68Ga-labeled radiopeptides and a method to assess its biological effectiveness.
10:01
In vitro Methylation Assay to Study Protein Arginine Methylation
0 Views •
Cited by 8 •
2014
Protein arginine methylation, catalyzed by a class of enzymes viz., protein arginine methyl transferases (PRMTs), is the process of enzymatic addition of methyl group(s) to arginines within proteins. The in vitro methylation assay is the most dependable tool for assessing the methylation status of known or novel PRMT substrates.
04:04
Radiolabeled Amino Acid Uptake Assay to Quantify Cellular Uptake of Amino Acids
0 Views •
2025
This video demonstrates an in vitro technique for estimating amino acid uptake by bone marrow-derived stromal cells. Na+-dependent amino acid transporters mediate the uptake of radiolabeled amino acids inside the cells, and the cellular uptake is estimated by measuring the radioactivity.
08:11
Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
0 Views •
Cited by 1 •
2021
These protocols provide the methodology used to assess the enzymatic activity of individual members of the protein arginine methyltransferase (PRMT) family in cells. Detailed guidelines on assessing PRMT activity using endogenous and exogenous biomarkers, methyl-arginine recognizing antibodies, and inhibitor tool compounds are described.
FAQs
Transport depends partly on the concentration gradient, which influences the direction and extent of arginine movement across a membrane. Cationic amino acid transport systems recognize arginine in its positively charged form, while substrate exchange can also regulate movement. These factors help determine how much arginine becomes available inside cells for protein synthesis, nitrogen metabolism, and signaling.
Substrate exchange allows transporter activity to depend on the movement of arginine relative to other substrates rather than on concentration alone. This provides an additional layer of control over intracellular arginine availability. Because arginine supports several cellular functions, changes in exchange activity may influence downstream processes such as signaling, nitric oxide production, and nitrogen handling.
Cellular arginine availability helps shape pathways linked to nitric oxide production and immune-cell activity. If transporter activity changes, the amount of arginine accessible within cells may also change, potentially modifying these functions. This relationship makes arginine transport relevant to medical research on immune responses, signaling abnormalities, and conditions in which nitric oxide biology is disrupted.
Researchers can examine arginine transport as part of the cellular processes associated with wound healing and metabolic disorders. Comparing transporter activity with changes in signaling, nitrogen metabolism, or cell function can help connect membrane transport to disease-related outcomes. This approach is useful because altered arginine handling may contribute to broader metabolic or tissue-repair abnormalities.
Tumor cells may be studied in relation to altered arginine transporter activity because transport can influence the intracellular supply of an amino acid required for cellular functions. Its relevance extends to tumor growth and response to therapy. Consequently, arginine transport research may support investigation of disease mechanisms, therapeutic vulnerabilities, and strategies for predicting or modifying treatment responses.
Medical research connects arginine transport with diagnostics, nutritional strategies, and drug development. Transport findings can provide context for interpreting nitric oxide production, immune-cell function, wound healing, and metabolic changes. In oncology, they may also help explain tumor behavior or therapy response. These applications make transporter activity a potential bridge between cellular mechanisms and clinical investigation.